Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Amdocs Sees Q4 EPS $1.67-$1.73 Vs $1.71 Est.; Revenue $1.24B-$1.28B Vs $1.27B Est.; Revises FY24 EPS Growth Guidance Range From 7%-11% To 8.5%-9.5%; Revises FY24 Revenue Growth Guidance Range From 1.6%-3.6% To 1.9%-2.7%

Author: Benzinga Newsdesk | August 07, 2024 04:18pm
Fourth Quarter Fiscal Year Outlook   
    
  In millions, except per share data 
  Q4 - 2024 
Revenue $1,240-$1,280 
GAAP Diluted earnings per share $1.34-$1.42 
Non-GAAP Diluted earnings per share $1.67-$1.73 

Fourth quarter revenue guidance assumes immaterial sequential impact from foreign currency fluctuations as compared to the third quarter of fiscal 2024

Fourth quarter non-GAAP diluted EPS guidance excludes equity-based compensation expense of approximately $0.18-$0.20 per share, amortization of purchased intangible assets and other acquisition-related costs of approximately $0.11 per share, changes in certain acquisitions related liabilities measured at fair value, and other, net of related tax effects

GAAP diluted EPS guidance does not include the impact of future expected restructuring charges

Full Year Fiscal 2024 Outlook      
       
  FY 2024 - Year-over -Year growth 
  Current guidance  Previous guidance 
Revenue Growth, as reported  1.9%-2.7%   1.6%-3.6% 
Revenue Growth, constant currency (1)  2.3%-3.1%   1.7%-3.7% 
GAAP Diluted earnings per share  7.4%-9.2%   7.0%-13.0% 
Non-GAAP Diluted earnings per share  8.5%-9.5%   7.0%-11.0% 
         
  FY 2024, in millions 
  Current guidance  Previous guidance 
Free Cash Flow (2) $700  $700 

Full year fiscal 2024 revenue guidance incorporates an expected unfavorable impact from foreign currency fluctuations of approximately 0.4% year-over-year, as compared with an unfavorable impact of about 0.1% year-over-year previously

Non-GAAP diluted earnings per share growth excludes equity-based compensation expense of approximately $0.72-$0.74 per share, amortization of purchased intangible assets and other acquisition-related costs of approximately $0.46 per share, restructuring charges of $0.35, changes in certain acquisitions related liabilities measured at fair value, and other, net of related tax effects

GAAP diluted EPS guidance does not include the impact of future expected restructuring charges

Non-GAAP operating margin is anticipated to be within a range of 18.1% to 18.7% for the full year fiscal 2024

Non-GAAP operating margin is comprised of GAAP operating margin, excluding amortization on purchased intangible assets and other, equity-based compensation expense, restructuring charges, and changes in certain acquisitions related liabilities measured at fair value

Non-GAAP effective tax rate is anticipated to be within a range of 13% to 17% for the full year fiscal 2024

Free cash flow(2) is comprised of cash flow from operations, less net capital expenditures and other, and excludes payments related to restructuring charges

The forward looking statements regarding our fourth fiscal quarter 2024 and full year fiscal 2024 guidance take into consideration the Company's current expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However, we note that market dynamics continue to shift rapidly and we cannot predict all possible outcomes, including those resulting from certain geopolitical events, the current inflationary environment, global or regional events, such as the COVID-19 pandemic and the prevailing level of macro-economic, business and operational uncertainty, which have created, and continue to create, a significant amount of uncertainty, or from current and potential customer consolidation or their other strategic corporate activities.

Posted In: DOX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist